|
| 38071573 | Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. | Thorax | 2024 |
| 36844970 | Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study. | Lancet Rheumatol | 2023 |
| 36099211 | A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings. | Arthritis and Rheumatology | 2023 |
| 35616586 | Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study. | Clin Exp Rheumatol | 2023 |
| 37605393 | Quality of Life and Disability in Chikungunya Arthritis. | | 2023 |
| 37967495 | 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis. | | 2023 |
| 37699654 | Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2). | | 2023 |
| 37696589 | Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3). | | 2023 |
| 37549898 | Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients. | | 2023 |
| 37158761 | Patterns of Involvement of the Hand Joints in Classical Rheumatoid Arthritis. | | 2023 |
| 36656454 | Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination. | | 2023 |
| 37269020 | Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis. | Arthritis Res Ther | 2023 |
| 36874209 | Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case-control study. | Lancet Rheumatol | 2023 |
| 37385296 | A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12-Month Findings. | | 2023 |
| 36549417 | Pathogenesis of chronic chikungunya arthritis: Resemblances and links with rheumatoid arthritis. | | 2023 |
| 37237405 | Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry. | | 2023 |
| 36725063 | Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares Using OMERACT Core Domains. | | 2023 |
| 36662442 | Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies. | | 2023 |
| 34875040 | Screening for preclinical parenchymal lung disease in rheumatoid arthritis. | Rheumatology (Oxford) | 2022 |
| 35772915 | Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis. | J Am Coll Cardiol | 2022 |
| 35907639 | Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis. | Thorax | 2022 |
| 35765565 | Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron. | medRxiv | 2022 |
| 36008814 | A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an | | 2022 |
| 35944947 | Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave. | Ann Rheum Dis | 2022 |
| 35738804 | Meaning of patient global assessment when joint counts are low in rheumatoid arthritis. | RMD Open | 2022 |
| 36271723 | From Canadian Living Guidelines to Global Living Guidelines: A Post Pandemic Effort. | Journal of Rheumatology | 2022 |
| 36324801 | Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study. | medRxiv | 2022 |
| 36575505 | Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial. | | 2022 |
| 35174462 | The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity. | Rheumatology and Therapy | 2022 |
| 34654733 | Dr. Kremer et al reply. | Journal of Rheumatology | 2022 |
| 34878629 | Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis. | Rheumatology and Therapy | 2022 |
| 30106792 | Transient Elastography for Monitoring for Hepatotoxicity in Rheumatoid Arthritis Patients on Long-term Methotrexate. | Journal of Clinical Rheumatology | 2021 |
| 33752237 | Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study. | Rheumatology (Oxford) | 2021 |
| 33950153 | Treatment of Severe Multicentric Reticulohistiocytosis With Upadacitinib. | JAMA Dermatology | 2021 |
| 34101387 | 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. | Arthritis Care Res (Hoboken) | 2021 |
| 34101376 | 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. | Arthritis Rheumatol | 2021 |
| 33615723 | Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation. | Arthritis and Rheumatology | 2021 |
| 34196510 | Perceptions and Challenges Experienced by African Physicians When Prescribing Methotrexate for Rheumatic Disease: An Exploratory Study. | ACR Open Rheumatology | 2021 |
| 32934137 | Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR). | Journal of Rheumatology | 2021 |
| 32876784 | Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis. | Clinical Rheumatology | 2021 |
| 33191286 | Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease. | J Rheumatol | 2021 |
| 33277981 | American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3. | Arthritis Rheumatol | 2021 |
| 33002337 | Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry. | Arthritis Care and Research | 2021 |
| 33397438 | Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies. | | 2021 |
| 33323534 | The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies. | Journal of Rheumatology | 2021 |
| 34438448 | Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease. | Blood advances | 2021 |
| 34757241 | Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study. | Semin Arthritis Rheum | 2021 |
| 31203222 | Correlates of Successful Rheumatoid Arthritis Flare Management: Clinician-driven Treatment, Home-based Strategies, and Medication Change. | Journal of Rheumatology | 2020 |
| 32020443 | Correction to: Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. | Clin Rheumatol | 2020 |
| 31958281 | Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis. | RMD Open | 2020 |